# OnCo record nct07100730 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07100730/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07100730", "NCT07100730" ;
  schema:name "Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma"@en ;
  schema:alternateName "IPAX-3"@en ;
  schema:description "A phase 3 trial of TLX-101-Tx + Lomustine in glioma & glioblastoma, run by Telix Pharmaceuticals (Innovations) Pty Limited, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07100730/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07100730> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-11-02" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:companies <https://onco.cc/companies/telix/> .